Irinotecan monotherapy as third line treatment for advanced gastric cancer patients refractory fluoropyrimidine, platinum and taxanes harboring UGT1A1*1/*1.*1/*6 or*1/*28N. Sugimoto,T. Yoshinami,T. Yagi,A. Hasegawa,F. Fujisawa,F. ImamuraAnnals of Oncology（2016）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
